4978 ReproCELL Incorporated - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4978

TSE Growth

ReproCELL Incorporated

159

JPY

-3

(-1.85%)

Dec 5, 1:29 pm JST

1.02

USD

Dec 4, 11:29 pm EST

Result

PTS

outside of trading hours

158.2

Dec 5, 1:30 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	2,234	-647	-507	-575	-7.6	0	May 13, 2022	J-GAAP
Mar, 2023	2,953	-356	-119	-305	-3.6	0	May 12, 2023	J-GAAP
Mar, 2024	2,426	-409	40	-31	-0.4	0	May 13, 2024	J-GAAP
Mar, 2025	2,978	-130	45	103	1.1	0	May 14, 2025	J-GAAP
Mar, 2026 Guidance	3,037	-268	-75	-75	-0.8	0	May 14, 2025	J-GAAP
YoY	+2.0%	-106.2%	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	Jul 10, 2020	1,295	-1,044	-893	-893	0	J-GAAP
Results	May 12, 2021	1,286	-1,048	-788	-812	0	J-GAAP
Mar, 2022	May 12, 2021	Available in future release
	May 10, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	May 10, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
	May 7, 2024
Results	May 13, 2024
Mar, 2025	May 13, 2024
	May 12, 2025
Results	May 14, 2025
Mar, 2026	May 14, 2025	3,037	-268	-75	-75	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2008	66	－	Available in future release
Mar, 2009	178	+169.7
Mar, 2010	221	+24.2
Mar, 2011	278	+25.8
Mar, 2012	316	+13.7
Mar, 2013	420	+32.9
Mar, 2014	460	+9.5
Mar, 2015	567	+23.3
Mar, 2016	1,066	+88.0
Mar, 2017	1,257	+17.9
Mar, 2018	926	-26.3
Mar, 2019	1,088	+17.5
Mar, 2020	1,199	+10.2
Mar, 2021	1,286	+7.3
Mar, 2022	2,234	+73.7
Mar, 2023	2,953	+32.2
Mar, 2024	2,426	-17.8
Mar, 2025	2,978	+22.8
Mar, 2026 Guidance	3,037	+2.0	-268	-106.2	-75	－	-0.8	－

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	2,426	-409	-17	-0.39	-0.36	0.28	-0.4
Mar, 2025	2,978	-130	-4.4	1.19	1.10	0.32	1.1
Mar, 2026 Guidance	3,037	-268	-8.8	-0.86	-0.80	0.32	-0.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	2,978	-45	45	103	1.1
Fiscal Year	Mar, 2025	Mar, 2013	Mar, 2025	Mar, 2025	Mar, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	1,377	-266	-189	-373	-4.4	0	May 12, 2023	J-GAAP
Oct - Mar, 2023	1,279	-168	-30	-91	-1.1	0	May 13, 2024	J-GAAP
Oct - Mar, 2024	1,658	19	148	207	2.2	0	May 14, 2025	J-GAAP
Oct - Mar, 2025 Guidance	2,063	278	408	411	4.3	0	Nov 13, 2025	J-GAAP
YoY	+24.4%	+1,363.2%	+175.7%	+98.6%	+94.2%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-356	-1,227	-140	-1,087	482	1,914	22.91	J-GAAP
Mar, 2024	-409	393	-11	404	544	2,939	32.47	J-GAAP
Mar, 2025	-130	-789	6	-795	680	2,823	29.19	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	1,147	-241	70	60	0.7	175.0	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	1,320	-149	-103	-104	-1.1	ー	Nov 13, 2024	J-GAAP
Apr - Sep, 2025	974	-546	-483	-486	-5.1	ー	Nov 13, 2025	J-GAAP
YoY	-26.2%	-266.4%	-368.9%	-367.3%	-350.9%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	629	-48	-12	-12	-0.1	-7.6	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	650	-120	-18	-79	-0.9	-18.5	May 13, 2024	J-GAAP
Apr - Jun, 2024	619	-115	-74	-75	-0.8	-18.6	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	701	-34	-29	-29	-0.3	-4.9	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	748	-31	70	73	0.8	-4.1	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	910	50	78	134	1.4	5.5	May 14, 2025	J-GAAP
Apr - Jun, 2025	475	-291	-301	-304	-3.2	-61.3	Aug 13, 2025	J-GAAP
Jul - Sep, 2025	499	-255	-182	-182	-1.9	-51.1	Nov 13, 2025	J-GAAP
YoY	-28.8%	-650.0%	-527.6%	-527.6%	-500.0%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	335	+2.4	Available in future release
Jan - Mar, 2021	337	+9.4
Apr - Jun, 2021	382	+127.4
Jul - Sep, 2021	607	+36.1
Oct - Dec, 2021	499	+49.0
Jan - Mar, 2022	746	+121.4
Apr - Jun, 2022	666	+74.3
Jul - Sep, 2022	910	+49.9
Oct - Dec, 2022	647	+29.7
Jan - Mar, 2023	730	-2.1
Apr - Jun, 2023	556	-16.5
Jul - Sep, 2023	591	-35.1
Oct - Dec, 2023	629	-2.8
Jan - Mar, 2024	650	-11.0
Apr - Jun, 2024	619	+11.3
Jul - Sep, 2024	701	+18.6
Oct - Dec, 2024	748	+18.9
Jan - Mar, 2025	910	+40.0
Apr - Jun, 2025	475	-23.3
Jul - Sep, 2025	499	-28.8	-255	-650.0	-182	-527.6	-1.9	-533.3

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	910	50	82	134	1.4
Fiscal Year	Sep, 2022	Mar, 2025	Jun, 2023	Mar, 2025	Mar, 2025

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	89.01	90.7	8,355	7,575	-515	ー	May 12, 2023	J-GAAP
Mar, 2024	93.41	91.8	9,052	8,308	-546	ー	May 13, 2024	J-GAAP
Mar, 2025	94.89	92.9	9,670	8,984	58	ー	May 14, 2025	J-GAAP
Apr - Sep, 2025	91.62	92.7	9,363	8,675	-428	ー	Nov 13, 2025	J-GAAP

ReproCELL Incorporated(4978) Financial Results